RNU6-299P

Across TCGA pan-cancer cohorts, RNU6-299P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU6-299P’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where RNU6-299P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-299P is over-expressed in tumor.

CHOL and LIHC are the cancer types where RNU6-299P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-299P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	Female	All	+0.740	<.001	1	view →
LIHC	All	III,IV	+0.233	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RNU6-299P–CHOL

Open the CHOL breakdown →